GovChime

6505-01-316-5049 Ibuprofen oral suspension

One item DLA buys: its open requests for quotation, approved sources and past DLA awards.

Overview

National Stock Number record

Open RFQs
1
Next due November 17, 2026
Last price paid
…
Standard price
$7.86 per BT
DLA's catalog price, not a price paid
Approved sources
1
One approved manufacturer listed
Awards on record
3
2007 to 2017
DLA demand
–

Identification

Item name
Ibuprofen oral suspension
NSG (group)
65 · Medical/dental/veterinary eqpt/supp
NIIN assigned
09-MAR-90
Unit
BT
NSN
6505-01-316-5049
NIIN
01-316-5049

Name, end product, NIIN date and unit: DLA's Federal Logistics Information System (PUB LOG). Source: the request-for-quotation (RFQ) files DLA publishes on DIBBS each day. An RFQ that is also a SAM.gov notice links to that notice. Return-by dates are DIBBS's.

Approved suppliers

Manufacturers and part numbers DLA has qualified for this item, and the part numbers in its catalog record

SupplierCAGECAGE statusPart status (RNCC / RNVC)Supplier part #Listed in
PADAGIS US LLC9MGE4A (Active)3 (Design control reference) / 2 (An item-identifying number)NDC45802-0952-26DLA approved-source file
0V9D6H (Obsolete entity has been discontinued)5 (Secondary reference) / 9 (Was the design control reference)NDC45802-0952-26FLIS part list

Source: DLA's approved-source file published with the RFQs and the part list of DLA's catalog record (FLIS). CAGE and part status are FLIS's codes with DLA's wording.

Pricing and awardees

Characteristics

Government-defined characteristics of this item (FLIS)

Hazardous and environmental

Hazardous material (HMIC)
P (No information in hmirs)

Product characteristics

CodeRequirementDescription
AKJAActive medicament medicinal strengthMILLIGRAMS IBUPROFEN PER 5 MILLILITERS 100.000
CBBLFeatures providedCHILD RESISTANT CLOSURE
ALJHFlavorFRUIT
CXCYPart name assigned by controlling agencyIBUPROFEN ORAL SUSPENSION USP 100MG/5ML FRUIT FLAVORED 120ML BT
CRLKPrimary container content quantityMILLILITERS 120.000 OR FLUID OUNCES 4.000
CQCTPrimary container typeBOTTLE
FEATSpecial featuresDO NOT FREEZE AND SHAKE WELL BEFORE USING. STORE AT 20 TO 25 C (68 TO 77 F)(SEE USP CONTROLLED ROOM TEMPERATURE).

Additional identifiers

II
0
DEMIL
A: No demilitarization required
Precious metals (PMIC)
A (Does not contain precious metal)
Schedule B
3004909225 (Cont argatroban/adenosine/amlodipine/esmolol/etc)
PINC
0066563
Criticality (CRIT CD)
X
On FedMall
Yes

Source: DLA's PUB LOG files (FLIS Data Electronic Reading Room), updated monthly; code wording from DLA's code table (P_HELP).

Major organizational entity (MOE) rules

How each service or agency buys and manages this item

RuleMOEAMCAMSCNIMSCIMCAACDSOR
A911Army (DA)1Suitable for competition (second or later time)ZCommercial or off-the-shelf item
FSGMAir Force (DF)1Suitable for competition (second or later time)ZCommercial or off-the-shelf item
MC55Marine Corps (DM)1Suitable for competition (second or later time)ZCommercial or off-the-shelf item
N9BLNavy (DN)1Suitable for competition (second or later time)ZCommercial or off-the-shelf item

Source: DLA's PUB LOG files (FLIS Data Electronic Reading Room), updated monthly; code wording from DLA's code table (P_HELP). AMC and AMSC wording: DFARS PGI 217.7506. Hover a code for DLA's wording.

Government organizations

The services and agencies that manage or use this item

OrganizationEffective dateUnit of issueUnit priceQty per unitControlled inventoryShelf lifeAcquisition adviceSource of supply
Army (DA)01-OCT-2025BT$6.011 (1)U (Unclassified)M (24 months)L (Local purchase)SMS (Defense logistics agency)
Air Force (DF)01-OCT-2025BT$6.011 (1)U (Unclassified)M (24 months)L (Local purchase)SMS (Defense logistics agency)
Marine Corps (DM)01-OCT-2025BT$6.011 (1)U (Unclassified)M (24 months)L (Local purchase)SMS (Defense logistics agency)
Navy (DN)01-FEB-2026BT$6.011 (1)U (Unclassified)M (24 months)L (Local purchase)SMS (Defense logistics agency)
DLA (DS)01-OCT-2026BT$7.861 (1)U (Unclassified)M (24 months)L (Local purchase)SMS (Defense logistics agency)

Source: DLA's PUB LOG files (FLIS Data Electronic Reading Room), updated monthly; code wording from DLA's code table (P_HELP). Unit prices are DLA's standard prices (its catalog price to its customers, with DLA's surcharge), not prices DLA paid.

Packaging

FLIS packaging data of this item

FLIS packaging

Level A
Z (Special requirement)
Level B
Z (Special requirement)
Unit container
ZZ (Special requirement)

Source: DLA's PUB LOG files (FLIS Data Electronic Reading Room), updated monthly; code wording from DLA's code table (P_HELP).

DIBBS RFQs

Recent DLA requests for quotation for this item on DIBBS, newest first: 1 open now

SolicitationNSNItem nameQtyUnitStd. priceLast priceEst. valueSet-asideTech docsPostedReturn by
SPE2DP27T0285DIBBS only6505-01-316-5049Ibuprofen oral suspension6BT$7.86 per BT……No set-asideNoNovember 11, 2026November 17, 20264 days left
SPE2DP27T0025DIBBS only6505-01-316-5049Ibuprofen oral suspension2BT$7.86 per BT……No set-asideNovember 11, 2026First seenOctober 7, 2026Closed
SPE2DP26T4225DIBBS only6505-01-316-5049Ibuprofen oral suspension5BT$7.86 per BT……No set-asideNovember 3, 2026First seenJuly 27, 2026Closed

→ These RFQs in the DIBBS list

“First seen”: an RFQ from DIBBS's file of all open RFQs, which gives no issue date. Source: the request-for-quotation (RFQ) files DLA publishes on DIBBS each day. An RFQ that is also a SAM.gov notice links to that notice. Return-by dates are DIBBS's.

DLA forecast

DLA's purchase forecast for the next 24 months, and its lead time

DLA's own figures

Lead time
administrative 19 days, production 120 days (139 in all)

Source: DLA's monthly files in its FOIA reading room: the 24-month demand forecast (what DLA expects to buy, not a commitment) and the ALT/PLT file (administrative lead time: requirement to award; production lead time: award to delivery).

DLA award history

3 award lines since 2007, 2 winning CAGEs

WinnerAwardsLast award
1UNB0DMS PHARMACEUTICAL GROUP INC2August 26, 2016
00E55Cardinal Health, Inc.1March 30, 2017
YearAwardsWinning CAGEs
201711
201611
200711

Source: DLA's award history files (its FOIA reading room: every DLA award line since 2013, refreshed monthly), plus the past awards listed in this item's RFQ documents that those files lack. Counts are award lines, not dollars; surplus buys are left out.

DLA awards for this item

2 awards from the item's award history, in FPDS

RankVendorObligated
1CARDINAL HEALTH, INC.$2,848,913
2DMS PHARMACEUTICAL GROUP INC$21,988
ContractAwardedAwardeeObligated
SPE2DP17C0001From the item's award historyApril 4, 2017CARDINAL HEALTH, INC.$2,848,913
SPE2DX15D9383/9202From the item's award historyAugust 26, 2016DMS PHARMACEUTICAL GROUP INC$21,988

Source: DLA award notices on SAM.gov for solicitations that included this item (DLA posts them above $25,000), and the contracts of this item's past DLA awards (DLA's award history files and the RFQs' procurement history), joined to FPDS by contract number (an order under a long-term contract by the order and its contract). Amounts are FPDS obligations; DIBBS order totals are not shown. Department of Defense actions appear in FPDS about 90 days after they are signed.

Winning bids